Minerva Neurosciences
NERV
$2.37
Share price
-0.84%
Change (1 day)
-48.59%
Change (1 year)
Categories
Minerva Neurosciences (NERV) - P/B ratio
P/B ratio as of May 2024 : -0.5775
According to Minerva Neurosciences
's latest financial reports the company has a price-to-book ratio of -0.5775.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Minerva Neurosciences - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -1.51 | 256.43% |
| 2022-12-31 | -0.4240 | -109.88% |
| 2021-12-31 | 4.29 | 126.02% |
| 2020-12-31 | 1.90 | -81.02% |
| 2019-12-31 | 10.0 | 244.06% |
| 2018-12-31 | 2.91 | 63.41% |
| 2017-12-31 | 1.78 | -53.89% |
| 2016-12-31 | 3.86 | 42.26% |
| 2015-12-31 | 2.71 | 25.85% |
| 2014-12-31 | 2.16 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Incyte INCY | 2.30 | -497.74% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | 2.47 | -526.92% | 🇺🇸 USA |
 Clovis Oncology CLVS | -0.0282 | -95.12% | 🇺🇸 USA |